Microenvironmental influences on human B-cell development

Immunological Reviews

Volumn 175, Issue , 2000, Pages 175-186

  Bertrand, F E ^a   Eckfeldt, C E ^a   Fink, J R ^a   Lysholm, A S ^a   Pribyl, J A R ^a   Shah, N ^a   LeBien, Tucker W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD34 ANTIGEN; LIGAND; NOTCH RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; FETUS; FETUS LIVER; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; IN VITRO STUDY; MAMMAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

APOPTOSIS; B-LYMPHOCYTES; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CYTOKINES; EMBRYONIC AND FETAL DEVELOPMENT; HEMATOPOIETIC STEM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-7; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 0033933697     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.017513.x     Document Type: Article

References (72)

1. 1. Rajewsky K. Clonal selection and learning in the immune system. Nature 1996;381:751-758.
2. 2. Burrows PD, Cooper MD. B cell development and differentiation. Curr Opin Immunol 1997;9:239-244.
3. 3. LeBien TW. Normal and abnormal human B-cell development. Blood (In press).
4. 4. Nuñez C, et al. B cells are generated throughout life in humans. J Immunol 1996;156:866-872.
5. 5. Wilson PC, Capra JD. The super-information age of immunoglobulin genetics. J Exp Med 1998;188:1973-1975.
6. 6. Pribyl JAR, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci USA 1996;93:10348-10353.
7. 7. Pribyl JAR, Shah N, Dittel BN, LeBien TW. Methods of purification and growth of human B cell precursors in bone marrow stromal cell-dependent cultures. In: Lefkovits I, ed. The immunology methods manual. New York: Academic Press; 1997. p. 902-923.
8. 8. Dittel BN, McCarthy JB, Wayner EA, LeBien TW. Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). Blood 1993;81:2272-2282.
9. 9. Ryan DH, Nuccie BL, Abboud CN, Winslow JM. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B-cell precursors to cultured bone marrow adherent cells. J Clin Invest 1991;88:995-1004.
10. 10. Moreau I, et al. Myofibroblastic stromal cells isolated from human bone marrow induce the proliferation of both early myeloid and B-lymphoid cells. Blood 1993;82:2396-2405.
11. 11. Murti KG, Brown PS, Kumagai MA, Campana D. Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp Cell Res 1996;226:47-58.
12. 12. Kurosaka D, LeBien TW, Pribyl JAR. Comparative studies of different stromal cell microenvironments in support of human B cell development. Exp Hematol 1999;27:1271-1281.
13. 13. Von Freeden-Jeffrey U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a non-redundant cytokine. J Exp Med 1995;181:1519-1526.
14. 14. Wolf ML, Weng W-K, Stieglbauer K, Shah N, LeBien TW. Functional effect of IL-7 increased CD19 expression on human B-cell precursors. J Immunol 1993;151:138-148.
15. 15. Billips LG, et al. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med 1995;181:973-981.
16. 16. Noguchi M, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147-157.
17. + severe combined immunodeficiency. Nat Genet 1998;20:394-397.
18. 18. Maachi P, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995;377:65-68.
19. 19. Russell SM, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995;270:797-800.
20. 20. Namikawa R, Muench MO, De Vries JE, Roncarolo M-G. The Flk2/Flt3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 1996;87:1881-1890.
21. - cord blood stem cells into B cell progenitors in vitro. Exp Hematol 1997;25:66-72.
22. 22. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999;13:2905-2927.
23. + B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 1994;22:321-328.
24. 24. Ray RJ, Furlonger C, Williams DE, Paige CJ. Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 1996;26:10-16.
25. + B cells in vitro and signals via a novel mechanism. J Immunol 1999;162:677-683.
26. 26. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-400.
27. 27. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312.
28. 18. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
29. 29. Fang W, et al. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 1996;4:291-299.
30. 30. Lu L, Chaudhury P, Osmond DG. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2. J Immunol 1999;162:1931-1940.
31. 31. Khaled AR, Kim K, Hofmeister R, Muegge K, Durum SK. Withdrawal of IL-7 induces bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci USA 1999;96:14476-14481.
32. 32. Shah N, Oseth LL, LeBien TW. Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment. Blood 1998;92:3817-3828.
33. 33. Melchers F. Fit for life in the immune system? Surrogate L chain tests H chains that test L chains. Proc Natl Acad Sci USA 1999;96:2571-2573.
34. 34. Kitamura D, Kudo A, Schaal S, Müller W, Melchers F, Rajewsky K. A critical role of λ5 protein in B cell development. Cell 1992;69:823-831.
35. 35. Martensson A, Argon Y, Melchers F, Dul JL, Martensson IL. Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice. Int Immunol 1999;11:453-460.
36. 36. Minegishi Y, Coustan-Smith E, Wang Y-H, Cooper MD, Campana D, Conley ME. Mutations in the human λ5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998;187:71-77.
37. 37. Wasserman R, et al. A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly. J Exp Med 1998;187:259-264.
38. H gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity 1997;7:357-368.
39. 39. Kline GH, et al. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional μ heavy chains. J Immunol 1998;161:1608-1618.
40. 40. Yel L, et al. Mutations in the μ heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996;335:1486-1493.
41. 41. Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. Mutations in Igα (CD79a) result in a complete block in B-cell development. J Clin Invest 1999;104:1115-1121.
42. 42. Tsukada S, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-290.
43. 43. Vetrie D, et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tryosine kinases. Nature 1993;361:226-233.
44. 44. Minegishi Y, et al. An essential role for BLNK in human B cell development. Science 1999;286:1954-1957.
45. 45. Ghia P, ten Boekel E, Sanz E, de la Hera A, Rolink A, Melchers F. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J Exp Med 1997;184:2217-2229.
46. 46. Wang Y-H, Nomura J, Faye-Petersen OM, Cooper MD. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression. J Immunol 1998;161:1132-1139.
47. 47. Bosma GC, Chang Y, Karasuyama H, Bosma MJ. Differential effect of an Igμ transgene on development of pre-B cells in fetal and adult SCID mice. Proc Natl Acad Sci USA 1999;96:11952-11957.
48. 48. Rolink AG, Winkler T, Melchers F, Anderson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 2000;191:1-9.
49. 49. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
50. + hematopoietic precursors. Blood 1994;83:2057-2062.
51. 51. Ellisen LW, et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991;66:649-661.
52. 52. Li L, et al. The human homolog of rat Jagged 1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998;8:43-55.
53. 53. Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein IR, Martin DIK. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci USA 1996;93:13014-13019.
54. 54. Varnum-Finney B, et al. The notch ligand, Jagged 1, influences the development of primitive hematopoietic precursor cells. Blood 1998;91:4084-4091.
55. 55. Robey E, et al. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 1996;87:483-492.
56. 56. Washburn T, et al. Notch activity influences the αβ versus γδ T cell lineage. Cell 1997;88:833-843.
57. 57. Deftos ML, He Y-W, Ojala EW, Bevan MJ. Correlating Notch signaling with thymocyte maturation. Immunity 1998;9:777-786.
58. 58. Jehn BM, Bielke W, Pear WS, Osborne BA. Protective effects of notch-1 on TCR-induced apoptosis. J Immunol 1999;162:635-638.
59. 59. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998;393:382-386.
60. 60. Struhl G, Adachi A. Nuclear access and action of notch in vivo. Cell 1998;93:649-660.
61. 61. Matsuno K, Go MJ, Sun X, Eastman DS, Artavanis-Tsakonas S. Suppressor of Hairless-independent events in Notch signaling imply novel pathway elements. Development 1997;124:4265-4273.
62. 62. Nofziger D, Miyamoto A, Lyons KM, Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 1999;126:1689-1702.
63. 63. Ordentlich P, et al. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 1998;18:2230-2239.
64. H gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood 1997;90:736-744.
65. 65. Radtke F, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999;10:547-558.
66. 66. Pui JC, et al. Notch 1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999;11:299-308.
67. 67. Carlesso N, Aster JC, Sklar J, Scadden DT. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 1999;93:838-848.
68. 68. Bigas A, Martin DI, Milner LA. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol 1998;18:2324-2333.
69. 69. Ray RJ, et al. Stromal cell-independent maturation of IL-7-responsive pro-B cells. J Immunol 1998;160:5886-5897.
70. 70. Haass C, De Strooper B. The presenilins in Alzheimer's disease - proteolysis holds the key. Science 1999;286:916-919.
71. 71. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA 1995;92:6414-6418.
72. 72. Candéias S, Muegge K, Durum SK. IL-7 receptor and VDJ recombination: trophic versus mechanistic actions. Immunity 1997;6:501-508.